51
|
Kovacs L, Su Y. Redox-Dependent Calpain Signaling in Airway and Pulmonary Vascular Remodeling in COPD. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2017; 967:139-160. [PMID: 29047085 PMCID: PMC7036267 DOI: 10.1007/978-3-319-63245-2_9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The calcium-dependent cytosolic, neutral, thiol endopeptidases, calpains, perform limited cleavage of their substrates thereby irreversibly changing their functions. Calpains have been shown to be involved in several physiological processes such as cell motility, proliferation, cell cycle, signal transduction, and apoptosis. Overactivation of calpain or mutations in the calpain genes contribute to a number of pathological conditions including neurodegenerative disorders, rheumatoid arthritis, cancer, and lung diseases. High concentrations of reactive oxygen and nitrogen species (RONS) originated from cigarette smoke or released by numerous cell types such as activated inflammatory cells and other respiratory cells cause oxidative and nitrosative stress contributing to the pathogenesis of COPD. RONS and calpain play important roles in the development of airway and pulmonary vascular remodeling in COPD. Published data show that increased RONS production is associated with increased calpain activation and/or elevated calpain protein level, leading to epithelial or endothelial barrier dysfunction, neovascularization, lung inflammation, increased smooth muscle cell proliferation, and deposition of extracellular matrix protein. Further investigation of the redox-dependent calpain signaling may provide future targets for the prevention and treatment of COPD.
Collapse
Affiliation(s)
- Laszlo Kovacs
- Department of Pharmacology & Toxicology, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA
| | - Yunchao Su
- Department of Pharmacology & Toxicology, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA.
- Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA.
- Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA.
- Research Service, Charlie Norwood Veterans Affairs Medical Center, Augusta, GA, 30912, USA.
| |
Collapse
|
52
|
Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé F, Pifarré J, Alsedà M, Ortega M. Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary Disease. Lung 2016; 195:77-85. [PMID: 27900466 DOI: 10.1007/s00408-016-9966-0] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2016] [Accepted: 11/21/2016] [Indexed: 10/20/2022]
Abstract
BACKGROUND Anxiety and depression are common entities in patients diagnosed with COPD. However, the impact that they have on the exacerbation of illness is scarcely studied. OBJECTIVE To determine if the presence of anxiety and depression is associated with a greater risk of frequent exacerbation (≥2 per year) in patients diagnosed with COPD. PATIENTS AND METHODS A cohort study that analysed frequent exacerbation and associated factors in 512 patients monitored during 2 years. Exacerbations were defined as events that required antibiotic/s and/or systemic corticosteroids (moderate) or hospitalization (serious). Variables of interest were recorded for each patient, including anxiety and depression (Hospital Anxiety and Depression Scale), and we analysed their association with frequent exacerbation through the adjusted odds ratio (aOR) by means of a logistic regression model. RESULTS The prevalence of anxiety/depression at the start of the study was of 15.6%. During the 2 years of monitoring, 77.9% of the patients suffered at least moderate-to-severe exacerbation. 54.1% were frequent exacerbators. Anxiety/depression were strongly associated with moderate-severe frequent exacerbation in the crude analysis (ORc = 2.28). In the multivariate analysis, the risk factors also associated with frequent exacerbation were being overweight (aOR 2.78); obesity (aOR 3.02); diabetes (aOR 2.56) and the associated comorbidity (BODEx) (ORa = 1.45). CONCLUSIONS The prevalence of anxiety/depression in COPD patients is high, and they are relevant risk factors in frequent exacerbation although the effect is lower in the multivariate analysis when adjusting for different variables strongly associated with exacerbation.
Collapse
Affiliation(s)
- Josep Montserrat-Capdevila
- Biomedical Research Institute (IRB) of Lleida, Avda Rovira Roure, 80, 25198, Lleida, Catalonia, Spain. .,Health Department, Public Health Agency of Catalonia, Avda Rovira Roure, 2, 25006, Lleida, Catalonia, Spain. .,Catalan Institute of Health (ICS), Consultori local de Bellvís (ABS Pla d'Urgell), c/ Major, 19, 25142, Bellvís, Catalonia, Spain.
| | - Pere Godoy
- Biomedical Research Institute (IRB) of Lleida, Avda Rovira Roure, 80, 25198, Lleida, Catalonia, Spain.,Health Department, Public Health Agency of Catalonia, Avda Rovira Roure, 2, 25006, Lleida, Catalonia, Spain.,Faculty of Medicine, University of Lleida, c/ de Montserrat Roig, 2, 25008, Lleida, Catalonia, Spain
| | - Josep Ramon Marsal
- Primary Care Research Institute (IDIAP) Jordi Gol, Universitat Autònoma of Barcelona, Avda de Rambla Ferran, 44, 25007, Lleida, Catalonia, Spain.,Epidemiology Unit, Cardiovascular Department, University Hospital Vall d'Hebron, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Catalonia, Spain
| | - Ferran Barbé
- Biomedical Research Institute (IRB) of Lleida, Avda Rovira Roure, 80, 25198, Lleida, Catalonia, Spain.,University Hospital Arnau de Vilanova, Avda Rovira Roure, 80, 25198, Lleida, Catalonia, Spain.,Respiratory Diseases Group, Biomedical Research Institute (IRB) of Lleida, Avda Rovira Roure, 80, 25198, Lleida, Catalonia, Spain.,Biomedical Research Centre/Respiratory Diseases Network (CIBERES), Avda Rovira Roure, 80, 25198, Lleida, Catalonia, Spain
| | - Josep Pifarré
- Biomedical Research Institute (IRB) of Lleida, Avda Rovira Roure, 80, 25198, Lleida, Catalonia, Spain.,Faculty of Medicine, University of Lleida, c/ de Montserrat Roig, 2, 25008, Lleida, Catalonia, Spain.,Psychiatry Department, University Hospital Santa Maria, Avda Rovira Roure, 44, 25198, Lleida, Catalonia, Spain
| | - Miquel Alsedà
- Biomedical Research Institute (IRB) of Lleida, Avda Rovira Roure, 80, 25198, Lleida, Catalonia, Spain.,Health Department, Public Health Agency of Catalonia, Avda Rovira Roure, 2, 25006, Lleida, Catalonia, Spain.,Faculty of Medicine, University of Lleida, c/ de Montserrat Roig, 2, 25008, Lleida, Catalonia, Spain
| | - Marta Ortega
- Primary Care Research Institute (IDIAP) Jordi Gol, Catalan Institute of Health (ICS), Avda de Rambla Ferran, 44, 25007, Lleida, Catalonia, Spain
| |
Collapse
|
53
|
Wong SLI, Sukkar MB. The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease. Br J Pharmacol 2016; 174:3-14. [PMID: 27759879 DOI: 10.1111/bph.13653] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2015] [Revised: 10/05/2016] [Accepted: 10/11/2016] [Indexed: 12/20/2022] Open
Abstract
The SPARC (secreted protein acidic and rich in cysteine) protein is matricellular molecule regulating interactions between cells and their surrounding extracellular matrix (ECM). This protein thus governs fundamental cellular functions such as cell adhesion, proliferation and differentiation. SPARC also regulates the expression and activity of numerous growth factors and matrix metalloproteinases essential for ECM degradation and turnover. Studies in SPARC-null mice have revealed a critical role for SPARC in tissue development, injury and repair and in the regulation of the immune response. In the lung, SPARC drives pathological responses in non-small cell lung cancer and idiopathic pulmonary fibrosis by promoting microvascular remodelling and excessive deposition of ECM proteins. Remarkably, although chronic airway conditions such as asthma and chronic obstructive pulmonary disease (COPD) involve significant remodelling in both the airway and vascular compartments, the role of SPARC in these conditions has thus far been overlooked. In this review, we discuss the role of SPARC in lung cancer and pulmonary fibrosis, as well as potential mechanisms by which it may contribute to the disease process in asthma and COPD.
Collapse
Affiliation(s)
- Sharon L I Wong
- Discipline of Pharmacy, Graduate School of Health, The University of Technology Sydney, Ultimo, NSW, Australia
| | - Maria B Sukkar
- Discipline of Pharmacy, Graduate School of Health, The University of Technology Sydney, Ultimo, NSW, Australia
| |
Collapse
|
54
|
Balla MMS, Desai S, Purwar P, Kumar A, Bhandarkar P, Shejul YK, Pramesh CS, Laskar S, Pandey BN. Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9. Sci Rep 2016; 6:36065. [PMID: 27811960 PMCID: PMC5095766 DOI: 10.1038/srep36065] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2016] [Accepted: 10/10/2016] [Indexed: 11/09/2022] Open
Abstract
Chronic obstructive pulmonary disease (COPD) patients are at higher risk of developing lung cancer and its metastasis, but no suitable biomarker has been reported for differential diagnosis of these patients. Levels of serum biomarkers (VEGF, IL-8, MMP-9 and MMP-2) were analyzed in these patients, which were compared with healthy donors (HD). Levels of VEGF (P < 0.005) and MMP-9 (P < 0.05) were significantly higher in COPD patients than HD. Compared to HD, a decrease in IL-8 (~8.1 folds; P < 0.0001) but an increase in MMP-9 (~1.6 folds; P < 0.05) levels were observed in the lung cancer patients. Cancer patients showed significantly (P < 0.005) lower levels of serum VEGF (1.9 folds) and IL-8 (~9 folds) than the COPD patients. VEGF level was significantly higher (2.6 folds; P < 0.0005) in metastatic than non-metastatic cancer patients. However, MMP-2 didn't show significant variation in these patients. The Youden's index (YI) values for lung cancer diagnosis in HD using IL-8 was 0.55 with 83.3% overall accuracy. VEGF was able to diagnose COPD in HD with better YI (0.38) and overall accuracy (70.6%). IL-8 was able to diagnose cancer in COPD patients and HD with YI values of 0.35, 0.55 with 71% and 83.3% overall accuracy, respectively.
Collapse
Affiliation(s)
- Murali M. S. Balla
- Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India
| | - Sejal Desai
- Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India
- Homi Bhabha National Institute, Anushakti Nagar, Mumbai 400 094, India
| | - Pallavi Purwar
- Tata Memorial Hospital, Dr E. Borges Road, Parel, Mumbai, 400012, India
| | - Amit Kumar
- Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India
- Homi Bhabha National Institute, Anushakti Nagar, Mumbai 400 094, India
| | - Prashant Bhandarkar
- Medical Division, Bhabha Atomic Research Centre, Anushakti Nagar, Mumbai 400 094, India
| | - Yogesh K. Shejul
- Homi Bhabha National Institute, Anushakti Nagar, Mumbai 400 094, India
- Medical Division, Bhabha Atomic Research Centre, Anushakti Nagar, Mumbai 400 094, India
| | - C. S. Pramesh
- Homi Bhabha National Institute, Anushakti Nagar, Mumbai 400 094, India
- Tata Memorial Hospital, Dr E. Borges Road, Parel, Mumbai, 400012, India
| | - S. Laskar
- Homi Bhabha National Institute, Anushakti Nagar, Mumbai 400 094, India
- Tata Memorial Hospital, Dr E. Borges Road, Parel, Mumbai, 400012, India
| | - Badri N. Pandey
- Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India
- Homi Bhabha National Institute, Anushakti Nagar, Mumbai 400 094, India
| |
Collapse
|
55
|
Yu H, Wang L, Wu Z, Yang Z. Status of and prospects for bronchoscopic lung volume reduction for patients with severe emphysema. Biosci Trends 2016; 10:344-356. [PMID: 27594047 DOI: 10.5582/bst.2016.01113] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Bronchoscopic lung volume reduction (BLVR) is a minimally invasive treatment for severe emphysema, providing treatment options for patients who are unable to undergo lung volume reduction surgery (LVRS) or lung transplantation. Current BLVR techniques include bronchoscopic volume reduction with valve implants, use of a lung volume reduction coil (LVRC), bronchoscopic thermal vapor ablation (BTVA), biological lung volume reduction (BioLVR), and use of airway bypass stents (ABS). To date, several randomized controlled trials of these bronchoscopic therapies have been conducted in patients with emphysema, and bronchoscopic volume reduction with valve implants remains the best approach thus far. Recent studies indicate that BLVR may be of great value in improving lung function, exercise capacity, and quality of life and that BLVR has the potential to replace conventional surgery for patients with severe emphysema. Optimal patient selection and the proper selection of the BLVR technique in accordance with patient characteristics are crucial to the success of BLVR. More multicenter, prospective, randomized controlled trials need to be conducted in the future to optimize the current selection strategy and evaluate the safety, efficiency, and long-term benefit of BLVR techniques.
Collapse
Affiliation(s)
- Hang Yu
- Department of Respiratory Medicine, Chinese PLA General Hospital
| | | | | | | |
Collapse
|
56
|
Type VIII collagen is elevated in diseases associated with angiogenesis and vascular remodeling. Clin Biochem 2016; 49:903-8. [DOI: 10.1016/j.clinbiochem.2016.05.023] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2016] [Revised: 05/19/2016] [Accepted: 05/20/2016] [Indexed: 12/21/2022]
|
57
|
Thomsen C, Theilig D, Herzog D, Poellinger A, Doellinger F, Schreiter N, Schreiter V, Schürmann D, Temmesfeld-Wollbrueck B, Hippenstiel S, Suttorp N, Hubner RH. Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy. Int J Chron Obstruct Pulmon Dis 2016; 11:1245-59. [PMID: 27354783 PMCID: PMC4907487 DOI: 10.2147/copd.s101003] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The exclusion of collateral ventilation (CV) and other factors affect the clinical success of endoscopic lung volume reduction (ELVR). However, despite its benefits, the outcome of ELVR remains difficult to predict. We investigated whether clinical success could be predicted by emphysema distribution assessed by computed tomography scan and baseline perfusion assessed by perfusion scintigraphy. Data from 57 patients with no CV in the target lobe (TL) were retrospectively analyzed after ELVR with valves. Pulmonary function tests (PFT), St George's Respiratory Questionnaire (SGRQ), and 6-minute walk tests (6MWT) were performed on patients at baseline. The sample was grouped into high and low levels at the median of TL perfusion, ipsilateral nontarget lobe (INL) perfusion, and heterogeneity index (HI). These groups were analyzed for association with changes in outcome parameters from baseline to 3 months follow-up. Compared to baseline, patients showed significant improvements in PFT, SGRQ, and 6MWT (all P≤0.001). TL perfusion was not associated with changes in the outcome. High INL perfusion was significantly associated with increases in 6MWT (P=0.014), and high HI was associated with increases in forced expiratory volume in 1 second (FEV1), (P=0.012). Likewise, there were significant correlations for INL perfusion and improvement of 6MWT (r=0.35, P=0.03) and for HI and improvement in FEV1 (r=0.45, P=0.001). This study reveals new attributes that associate with positive outcomes for patient selection prior to ELVR. Patients with high perfusions in INL demonstrated greater improvements in 6MWT, while patients with high HI were more likely to respond in FEV1.
Collapse
Affiliation(s)
- Christian Thomsen
- Department of Internal Medicine/Infectious Diseases and Respiratory Medicine
| | - Dorothea Theilig
- Institute of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Dominik Herzog
- Department of Internal Medicine/Infectious Diseases and Respiratory Medicine
| | | | - Felix Doellinger
- Institute of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Nils Schreiter
- Institute of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Vera Schreiter
- Institute of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Dirk Schürmann
- Department of Internal Medicine/Infectious Diseases and Respiratory Medicine
| | | | - Stefan Hippenstiel
- Department of Internal Medicine/Infectious Diseases and Respiratory Medicine
| | - Norbert Suttorp
- Department of Internal Medicine/Infectious Diseases and Respiratory Medicine
| | - Ralf-Harto Hubner
- Department of Internal Medicine/Infectious Diseases and Respiratory Medicine
| |
Collapse
|
58
|
Chronic obstructive pulmonary disease: A guide for the primary care physician. Dis Mon 2016; 62:164-87. [DOI: 10.1016/j.disamonth.2016.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
59
|
Heise RL, Link PA, Farkas L. From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling. Front Pediatr 2016; 4:80. [PMID: 27583245 PMCID: PMC4988064 DOI: 10.3389/fped.2016.00080] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Accepted: 07/20/2016] [Indexed: 01/27/2023] Open
Abstract
The field of stem cell biology, cell therapy, and regenerative medicine has expanded almost exponentially, in the last decade. Clinical trials are evaluating the potential therapeutic use of stem cells in many adult and pediatric lung diseases with vascular component, such as bronchopulmonary dysplasia (BPD), chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), or pulmonary arterial hypertension (PAH). Extensive research activity is exploring the lung resident and circulating progenitor cells and their contribution to vascular complications of chronic lung diseases, and researchers hope to use resident or circulating stem/progenitor cells to treat chronic lung diseases and their vascular complications. It is becoming more and more clear that progress in mechanobiology will help to understand the various influences of physical forces and extracellular matrix composition on the phenotype and features of the progenitor cells and stem cells. The current review provides an overview of current concepts in the field.
Collapse
Affiliation(s)
- Rebecca L Heise
- Department of Biomedical Engineering, School of Engineering, Virginia Commonwealth University , Richmond, VA , USA
| | - Patrick A Link
- Department of Biomedical Engineering, School of Engineering, Virginia Commonwealth University , Richmond, VA , USA
| | - Laszlo Farkas
- Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, School of Medicine, Virginia Commonwealth University , Richmond, VA , USA
| |
Collapse
|
60
|
Shahriary A, Seyedzadeh MH, Ahmadi A, Salimian J. The footprint of TGF-β in airway remodeling of the mustard lung. Inhal Toxicol 2015; 27:745-53. [PMID: 26606948 DOI: 10.3109/08958378.2015.1116645] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Mustard lung is a major pulmonary complication in individuals exposed to sulfur mustard (SM) gas during the Iran-Iraq war. It shares common pathological and clinical features with some chronic inflammatory lung disorders, particularly chronic obstructive pulmonary disease (COPD). Airway remodeling, which is one of the main causes of lung dysfunction and the dominant phenomenon of chronic pulmonary diseases, is seen in the mustard lung. Among all mediators involved in the remodeling process, the transforming growth factor (TGF)-β plays a pivotal role in lung fibrosis and consequently in the airway remodeling. Regarding the high levels of this mediator detected in mustard lung patients, in the present study, we have discussed the possible roles of TGF-β in airway remodeling (including epithelial layer damage, subepithelial fibrosis and angiogenesis). Finally, based on TGF-β targeting, we have reviewed new airway remodeling therapeutic approaches.
Collapse
Affiliation(s)
- Alireza Shahriary
- a Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences , Tehran , Iran
| | - Mir Hadi Seyedzadeh
- b Department of Immunology , School of Public Health, Tehran University of Medical Sciences , Tehran , Iran , and
| | - Ali Ahmadi
- c Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences , Tehran , Iran
| | - Jafar Salimian
- a Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences , Tehran , Iran
| |
Collapse
|
61
|
Larsson-Callerfelt AK, Weitoft M, Nihlberg K, Bjermer L, Westergren-Thorsson G, Tufvesson E. iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma. Pulm Pharmacol Ther 2015; 34:64-71. [PMID: 26362859 DOI: 10.1016/j.pupt.2015.09.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2015] [Revised: 08/24/2015] [Accepted: 09/06/2015] [Indexed: 02/07/2023]
Abstract
INTRODUCTION A high level of exhaled nitric oxide (NO) is a marker for inflammation in the airways of asthmatic subjects. However, little is known about how NO and inducible nitric oxides synthase (iNOS) activity may affect remodelling in the distal lung. We hypothesized that there is a link between iNOS and ongoing remodelling processes in the distal lung of mild asthmatics. METHODS Patients with mild asthma (n = 6) and healthy control subjects (n = 8) were included. Exhaled NO was measured at different flow rates and alveolar NO concentrations were calculated. For studies of remodelling processes in the distal lung, primary fibroblasts were grown from transbronchial biopsies and stimulated with unselective and selective NOS inhibitors or a NO donor. The mRNA expression of iNOS and synthesis of NO (indirectly as nitrite/nitrate) were measured and distal lung fibroblast synthesis of the extracellular matrix proteoglycans were analysed. RESULTS The distal lung fibroblasts expressed iNOS, and there was a tendency of higher expression in fibroblasts from patients with asthma. The selective iNOS inhibitor 1400 W inhibited iNOS expression and NO synthesis in fibroblasts from patients with asthma (p = 0.031). Treatment with 1400 W significantly increased synthesis of the proteoglycan versican (p = 0.018) in distal fibroblasts from patients with asthma whereas there were no effects in fibroblasts from control subjects. CONCLUSIONS Our data suggest that there is a link between iNOS and remodelling in the distal lung of subjects with mild asthma and that iNOS could have a modulatory role in pathological airway remodelling.
Collapse
Affiliation(s)
| | - Maria Weitoft
- Lung Biology, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
| | - Kristian Nihlberg
- Lung Biology, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
| | - Leif Bjermer
- Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
| | | | - Ellen Tufvesson
- Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
| |
Collapse
|
62
|
Mcleod VM, Chan LJ, Ryan GM, Porter CJ, Kaminskas LM. Optimal PEGylation can Improve the Exposure of Interferon in the Lungs Following Pulmonary Administration. J Pharm Sci 2015; 104:1421-30. [DOI: 10.1002/jps.24353] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Revised: 12/18/2014] [Accepted: 12/19/2014] [Indexed: 11/07/2022]
|
63
|
Álvarez-Santos M, Ramos-Ramírez P, Gutiérrez-Aguilar F, Sánchez-Hernández S, Lascurain R, Olmos-Zuñiga R, Jasso-Victoria R, Bobadilla NA, Bazan-Perkins B. Antigen-induced airway hyperresponsiveness and obstruction is related to caveolin-1 expression in airway smooth muscle in a guinea pig asthma model. Clin Transl Allergy 2015; 5:14. [PMID: 25977751 PMCID: PMC4431535 DOI: 10.1186/s13601-015-0058-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2014] [Accepted: 03/07/2015] [Indexed: 01/15/2023] Open
Abstract
BACKGROUND Caveolin-1 is a fundamental signalling scaffold protein involved in contraction; however, the role of caveolin-1 in airway responsiveness remains unclear. We evaluated the relationship between caveolin-1 expression in airway smooth muscle (ASM) and antigen-induced airway responsiveness and obstruction in a guinea pig asthma model. METHODS Airway obstruction in sensitised guinea pigs, induced by antigenic (ovalbumin) challenges administered every 10 days, was measured. Antigen-induced responsiveness to histamine and the expression of caveolin-1 and cavin 1, 2 and 3 were evaluated at the third ovalbumin challenge. The control group received saline solution instead of ovalbumin. RESULTS After the first challenge, antigen exposure induced a transient airway obstruction and airway hyperresponsiveness, high levels of IL-4 and IL-5 in lung and airway globet cells proliferation at the third antigenic challenge. Caveolin-1 mRNA levels in total lung decreased in the experimental group compared with controls. Flow cytometric analysis of ASM from the experimental group showed a high number of cells expressing caveolin-1 compared with controls. This increase was confirmed by western blot. Airway obstruction and hyperresponsiveness correlated with the degree of increased caveolin-1 expression in ASM cells (P < 0.05; r = 0.69 and -0.52, respectively). The expression of cavins 1, 2 and 3 in ASM also increased in the experimental group compared to controls. Immunohistochemical findings reveal that differences in ASM caveolin-1 were not evident between groups. Nevertheless, a marked decrease in caveolin-1 and caspase 3 was observed in the pulmonary vascular smooth muscle of asthma model compared with controls. Histological analysis did not reveal differences in smooth muscles mass or subepithelial fibrosis levels in airways between groups. However, an enlargement of smooth muscle mass was observed in the pulmonary microvessels of experimental animals. This enlargement did not induce changes in pulmonary or systemic arterial pressures. CONCLUSIONS Our data suggest that caveolin-1 expression in ASM has a crucial role in the development of antigen-induced airway obstruction and hyperresponsiveness in a guinea pig asthma model. In addition, the asthma model in guinea pigs appears to induce a contractile smooth muscle phenotype in the airways and a proliferative smooth muscle phenotype in pulmonary vessels.
Collapse
Affiliation(s)
- Mayra Álvarez-Santos
- />Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Departamento de Hiperreactividad Bronquial, Calzada de Tlalpan, 4502 Mexico
| | - Patricia Ramos-Ramírez
- />Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Departamento de Hiperreactividad Bronquial, Calzada de Tlalpan, 4502 Mexico
| | - Fernando Gutiérrez-Aguilar
- />Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Departamento de Hiperreactividad Bronquial, Calzada de Tlalpan, 4502 Mexico
| | - Sandra Sánchez-Hernández
- />Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Departamento de Hiperreactividad Bronquial, Calzada de Tlalpan, 4502 Mexico
| | - Ricardo Lascurain
- />Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, México, DF Mexico
| | - Raúl Olmos-Zuñiga
- />Departamento de Cirugía Experimental, Instituto Nacional de Enfermedades,Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan, 4502 Mexico
| | - Rogelio Jasso-Victoria
- />Departamento de Cirugía Experimental, Instituto Nacional de Enfermedades,Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan, 4502 Mexico
| | - Norma A Bobadilla
- />Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México, Mexico
- />Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Nephrology, México, Mexico
| | - Blanca Bazan-Perkins
- />Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Departamento de Hiperreactividad Bronquial, Calzada de Tlalpan, 4502 Mexico
| |
Collapse
|